Treatment of High Risk Adult Acute Lymphoblastic Leukemia

NCT00853008 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: Vincristine
DRUG: Daunorubicin
DRUG: Prednisone
DRUG: Mitoxantrone
DRUG: Cytosine Arabinoside
DRUG: Dexamethasone
DRUG: Methotrexate (MTX)
DRUG: Cytarabine
DRUG: ASP
DRUG: Mercaptopurine
DRUG: Teniposide
DRUG: Hydrocortisone

Sponsor

PETHEMA Foundation